Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA195432
Max Phase: Preclinical
Molecular Formula: C21H24Cl2N4O2
Molecular Weight: 435.36
Molecule Type: Small molecule
Associated Items:
ID: ALA195432
Max Phase: Preclinical
Molecular Formula: C21H24Cl2N4O2
Molecular Weight: 435.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc2c(cc1N1CCN(C)CC1)N(C(=O)Nc1cccc(Cl)c1Cl)CC2
Standard InChI: InChI=1S/C21H24Cl2N4O2/c1-25-8-10-26(11-9-25)18-13-17-14(12-19(18)29-2)6-7-27(17)21(28)24-16-5-3-4-15(22)20(16)23/h3-5,12-13H,6-11H2,1-2H3,(H,24,28)
Standard InChI Key: DJTDQOVOQOPRSJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 435.36 | Molecular Weight (Monoisotopic): 434.1276 | AlogP: 4.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 48.05 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.72 | CX Basic pKa: 7.40 | CX LogP: 4.03 | CX LogD: 3.73 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.78 | Np Likeness Score: -1.66 |
1. Wyman PA, Marshall HR, Flynn ST, King RJ, Thompson M, Smith PW, Hadley MS, Price GW, Scott CM, Dawson LA.. (2005) Identification of a potent and selective 5-HT1B receptor antagonist., 15 (21): [PMID:16153839] [10.1016/j.bmcl.2005.07.085] |
Source(1):